HOME >> BIOLOGY >> NEWS
OneWorld Health selects Odyssey Research for phase 4 study in India

SAN FRANCISCO, USA / NEW DELHI, INDIA March 28, 2007 -- The Institute for OneWorld Health, a US-based non-profit pharmaceutical company that develops drugs for people with neglected diseases in the developing world, today announced the selection of Odyssey Research, a Bismarck, North Dakota-based clinical trial management organization (TMO) with offices in New Delhi, India, to support its upcoming Phase 4 pharmacovigilance and access study of Paromomycin Intramuscular (IM) Injection for the treatment of visceral leishmaniasis (VL) in India. With approximately 500,000 new cases occurring annually, visceral leishmaniasis, also known as kala-azar or black fever, is the worlds second most deadly parasitic disease following malaria.

"We welcome Odyssey Research as part of our team to further develop Paromomycin IM Injection as a safe, affordable and effective treatment for a major public health problem in India," said Dr. Ahvie Herskowitz, OneWorld Healths Chief Medical Officer. "Odysseys clinical trial management capabilities and depth of experience in India make them a good fit for this important post-approval Phase 4 study."

Odyssey Research will perform regular monitoring of seven clinical sites for the pharmacovigilance module in the Phase 4 study. The study, scheduled to begin later this year, will be conducted in the state of Bihar, India.

The first module will enroll 500 patients in a pharmacovigilance study to confirm the safety and efficacy of Paromomycin IM Injection in an outpatient setting. Over the next three years, up to an additional 1500 patients will be included in two subsequent access modules that will monitor the effectiveness of a progressively extending network of treatment facilities and related logistics systems throughout rural Bihar. The results of the Phase 4 study are intended to provide a model for administering Paromomycin IM Injection safely and effectively in an outpatient setting in remote areas wher
'"/>

Contact: Hal Kane
Hkane@prandcompany.com
415-307-7092
Institute for OneWorld Health
28-Mar-2007


Page: 1 2

Related biology news :

1. Institute for OneWorld Health hosts global health seminar at AAAS Annual Meeting
2. Institute for OneWorld Health awarded $46 million grant to combat diarrheal disease
3. Institute for OneWorld Health hosts panels at ASTMH
4. Institute for OneWorld Health to exhibit at BIO
5. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
6. OneWorld Health awarded Sapling Foundation grant
7. OneWorld Health receives multimillion dollar grant for next steps in control of deadly disease
8. Institute for OneWorld Health CEO speaks at 2005 World Life Sciences Forum, BioVision
9. Institute for OneWorld Health awarded Skoll Foundations Social Entrepreneurship Award
10. OneWorld Health named business leader in public health on 2004 Scientific American 50
11. OneWorld Health presents preliminary clinical trial results at ASTMH

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2020)... ... August 21, 2020 , ... The August edition of ... now available on the company’s global website. Crystallography Times—an electronic newsletter published by ... news and crystallographic research. , The latest issue of Crystallography Times introduces ...
(Date:8/21/2020)... ... August 19, 2020 , ... ... SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty years. Together ... book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman ... Operations executive with expertise in clinical trial planning and feasibility, regulatory inspection readiness, ... Consultant. Throughout his career, Mr. Movahhed has helped design and manage oncology, neurology, ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... ... August 29, 2020 , ... DuPont Nutrition ... in Wuxi, China. The new plant operation will provide the local animal production ... , “This facility will improve the flexibility of our offerings to the ...
(Date:8/12/2020)... ... August 12, 2020 , ... ... International), a global leader in FDA compliance consulting has been named on its ... companies. The list represents a unique look at the most successful companies within ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... today announced the launch of its new tagline, “BUILDING FOR LIFE.” The adoption ... industry and around the globe, requiring fast track capacity to provide patients with ...
(Date:7/31/2020)... ... , ... The SDX® Respiratory Gating System , trusted ... its 20th anniversary of worldwide use. Introduced in the US over the past ... of Pennsylvania, University of Michigan, University of Maryland, University of California San Francisco—and ...
Breaking Biology Technology:
Cached News: